ARCHIVES

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

More RFPs For Smoking/Health Projects Planned For Release As Subcontracts For Enviro Control

March 14, 1975

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014